Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
The mean age was 47 years
J.PangM
The discovery and development of HMG-CoA reductase inhibitors
A.CondonK
The effects of valproic acid neurotoxicity on aggressive behavior in zebrafish autism model
Lilly's 2025 guidance of USD 5861 billion implies continued 32% growth momentum, validated by the SURMOUNT-5 Phase 3b head-to-head trial result: Zepbound demonstrated 47% greater relative weight loss compared to Wegovy the most commercially consequential head-to-head data in the obesity market
US$ 29.43
US$ 27.76
US$ 29.37
US$ 22.20
